PROFESSIONAL EDITION

The largest community of pharma leaders

Hospital News

Altasciences Performs Phase I Studies for FDA Approval of Vibegron

LAVAL, Quebec--(BUSINESS WIRE)--Altasciences is pleased to have contributed to the recent FDA approval of Vibegron, by performing three early phase clinical trials. Vibegron is...

PhysIQ Saw Significant Adoption of Their AI Technology in 2020

CHICAGO--(BUSINESS WIRE)--PhysIQ, Inc. will mark 2020 as a very important year-to-date for the leader in furthering acceptance and adoption of its digital medicine platform....

Turnstone Biologics Acquires Novel Cell Therapy Platform

NEW YORK--(BUSINESS WIRE)--Acquisition of Myst Therapeutics adds proprietary tumor infiltrating lymphocyte (“TIL”) technology and programs to Turnstone’s growing portfolio Source Read More

Recent Articles